VCEL Vericel Earnings and EPS analysis

Relative Growth: Rel. Growth: 93

Relative Strength: Rel. Strength: 39

Relative Valuation: Rel. Valuation: 47

Relative Profitability: Rel. Profitability: 74

EPS in 2026 (TTM): $0.43

Last Report Period Date: Mar 31, 2026

Currently, VCEL's 12-month EPS stands at $0.43, according to the most recent financial reports. Vericel's earnings per share in 2025 was reported at $0.33, marking a rise from $0.21 in 2024. VCEL recorded an EPS of -$0.12 for the quarterly period ending on Mar 31, 2026.

VCEL earnings history

Historical annual and quarterly earnings per share (EPS) data for Vericel

EPS (TTM)

$0.43

EPS Growth YoY (Quarterly)

47.8%

EPS (Quarterly)

-$0.12

EPS Growth (Quarterly)

-126.1%

In 2025, Vericel's earnings per share was $0.33, a rise of 57.1% from $0.21 in 2024. The quarterly earnings per share for the period ending Mar 31, 2026, was -$0.12, showing a 47.8% increase compared to the same quarter last year. The trailing twelve months EPS for VCEL is $0.43 as of March 2026. Vericel's full-year EPS for 2024 was $0.21, a 400% rise compared to the previous year.

VCEL earnings chart

VCEL EPS growth history

Earnings per share growth rates over time

EPS Growth YoY (Quarterly)

47.8%

EPS growth YoY

57.1%

EPS growth 3Y avg

N/A

EPS growth 5Y avg

40.6%

In the past 12 months, Vericel has recorded an earnings per share growth rate of 47.8% (YoY, quarterly). In the last five years, the company had an average annual EPS growth of 40.6%.

VCEL Earnings Waterfall

Breakdown of revenue, profit and net income for Vericel

VCEL Earnings vs Peers

What are the earnings of VCEL compared to its peers

Stock name	Price to Earnings	EPS grwoth 1Y	EPS grwoth 3Y	EPS grwoth 5Y
RPRX Royalty Pharma plc	28.96	-6.8%	161.6%	6.3%
VCEL Vericel Corp	82.91	57.1%	N/A	40.6%
NEOG Neogen Corp	N/A	-12,475%	N/A	N/A

All data is based on quarterly TTM periods, unless otherwise specified.